首页> 外文OA文献 >Interferon regulatory factor 4 sustains CD8+ T cell expansion and effector differentiation
【2h】

Interferon regulatory factor 4 sustains CD8+ T cell expansion and effector differentiation

机译:干扰素调节因子4维持CD8 + T细胞扩增和效应子分化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Upon infection, CD8(+) T cells undergo a stepwise process of early activation, expansion, and differentiation into effector cells. How these phases are transcriptionally regulated is incompletely defined. Here, we report that interferon regulatory factor 4 (IRF4), dispensable for early CD8(+) T cell activation, was vital for sustaining the expansion and effector differentiation of CD8(+) T cells. Mechanistically, IRF4 promoted the expression and function of Blimp1 and T-bet, two transcription factors required for CD8(+) T cell effector differentiation, and simultaneously repressed genes that mediate cell cycle arrest and apoptosis. Selective ablation of Irf4 in peripheral CD8(+) T cells impaired antiviral CD8(+) T cell responses, viral clearance, and CD8(+) T cell-mediated host recovery from influenza infection. IRF4 expression was regulated by T cell receptor (TCR) signaling strength via mammalian target of rapamycin (mTOR). Our data reveal that IRF4 translates differential strength of TCR signaling into different quantitative and qualitative CD8(+) T cell response
机译:感染后,CD8(+)T细胞经历早期活化,扩增和分化为效应细胞的逐步过程。这些阶段如何转录调控尚未完全定义。在这里,我们报告说,早期CD8(+)T细胞活化所必需的干扰素调节因子4(IRF4)对于维持CD8(+)T细胞的扩增和效应分化至关重要。从机制上讲,IRF4促进了Blimp1和T-bet(CD8(+)T细胞效应子分化所需的两个转录因子)的表达和功能,并同时抑制了介导细胞周期停滞和凋亡的基因。 Irf4在外周CD8(+)T细胞中的选择性消融损害了抗病毒CD8(+)T细胞反应,病毒清除和CD8(+)T细胞介导的流感感染宿主恢复。 IRF4表达受雷帕霉素(mTOR)哺乳动物靶标的T细胞受体(TCR)信号强度调节。我们的数据表明,IRF4将TCR信号的不同强度转化为不同的定量和定性CD8(+)T细胞应答

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号